価格表

在庫・価格 : 2024年05月18日 08時17分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
MMP-9, Human, Recombinant
データシート
911-MP-010 RSDアールアンドディー システムス
R&D Systems, Inc.
10 μg ¥103,000
(未発注)
追加

在庫・価格 : 2024年05月18日 08時17分 現在

MMP-9, Human, Recombinant

  • 商品コード:911-MP-010
  • メーカー:RSD
  • 包装:10μg
  • 価格: ¥103,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 L辿vesque JP et al. Granulocyte colony-stimulating factor induces the release in the bone marrow of proteases that cleave c-KIT receptor (CD117) from the surface of hematopoietic progenitor cells. Exp. Hematol. 2003 Feb;31(2):109-17
L辿vesque JP et al
2003/01/01
Species: Human, Application: Enzyme Activity, Sample type: recombinant SCFR PubMed
2 Breuer E et al. Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids. J. Med. Chem. 2004 May;47(11):2826-32
Breuer E et al
2004/01/01
Application: Enzyme Activity, Sample type: Fluorogenic Substrate PubMed
3 Nie J et al. Rapid inactivation of alpha-1-proteinase inhibitor by neutrophil specific leukolysin/membrane-type matrix metalloproteinase 6. Exp. Cell Res. 2004 Jun;296(2):145-50
Nie J et al
2004/01/01
Application: Enzyme Activity, Sample type: D10 affinity-matured variant of hVbeta2 PubMed
4 Tayebjee MH et al. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Am. J. Hypertens. 2
Tayebjee MH et al
2004/01/01
Application: ELISA Standard, Sample Type: Plasma (Not Specified) PubMed
5 Tayebjee MH et al. Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension Relationship to tissue Doppler indices of diastolic relaxation. Am. J. Hypertens. 2004 Sep;17(9):770-4
Tayebjee MH et al
2004/01/01
Application: ELISA Standard PubMed
6 Tayebjee MH et al. Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2. Thromb. Res. 2005
Tayebjee MH et al
2005/01/01
Application: ELISA Standard PubMed
7 Hashimoto T et al. Suppression of MMP-9 by doxycycline in brain arteriovenous malformations. BMC Neurol 2005 Jan;5(1):1
Hashimoto T et al
2005/01/01
Application: Zymography Positive Control PubMed
8 Leufgen H et al. Collagenase expression and activity is modulated by the interaction of collagen types, hypoxia, and nutrition in human lung cells. J. Cell. Physiol. 2005 Jul;204(1):146-54
Leufgen H et al
2005/01/01
Sample Type: gelatin PubMed
9 Yan P et al. Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ. J. Biol. Chem. 2006 Aug;281(34):24566-74
Yan P et al
2006/01/01
Species: Human, Application: Bioassay, Sample type: Amyloid B Fibrils PubMed
10 Zhou BB et al. Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer. Cancer Cell 2006 Jul;10(1):39-50
Zhou BB et al
2006/01/01
Application: Enzyme Assay PubMed
11 Borrelli V et al. Role of platelet-derived growth factor and transforming growth factor beta1 the in the regulation of metalloproteinase expressions. Surgery 2006 Sep;140(3):454-63
Borrelli V et al
2006/01/01
Species: Human, Application: Western Blot Control, Sample type: Cell Supernates PubMed
12 Turner NA et al. Selective gene silencing of either MMP-2 or MMP-9 inhibits invasion of human saphenous vein smooth muscle cells. Atherosclerosis 2007 Jul;193(1):36-43
Turner NA et al
2007/01/01
Species: Human, Application: Bioassay, Sample type: Whole Cells PubMed
13 Fridman JS et al. Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancer. Clin. Cancer Res. 2007 Mar;13(6):1892-902
Fridman JS et al
2007/01/01
Application: Bioassay, Sample Type: Peptide Substrate PubMed
14 Gaggar A et al. Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients. Am. J. Physiol. Lung Cell Mol. Physiol. 2007 Jul;293(1):L96-L104
Gaggar A et al
2007/01/01
Species: Human, Application: Western Blot Control PubMed
15 Zhao Z et al. Borrelia burgdorferi-induced monocyte chemoattractant protein-1 production in vivo and in vitro. Biochem. Biophys. Res. Commun. 2007 Jun;358(2):528-33
Zhao Z et al
2007/01/01
Application: Zymography Positive Control PubMed
16 Zou Y et al. Targeting matrix metalloproteinases and endothelial cells with a fusion peptide against tumor. Cancer Res. 2007 Aug;67(15):7295-300
Zou Y et al
2007/01/01
Species: Human, Application: Enzyme Activity PubMed
17 Mydel P et al. Neutrophil elastase cleaves laminin-332 (laminin-5) generating peptides that are chemotactic for neutrophils. J. Biol. Chem. 2008 Apr;283(15):9513-22
Mydel P et al
2008/01/01
Species: Human, Application: Enzyme Activity, laminin gamma2 peptide PubMed
18 Gonzalez RM et al. Development and validation of sandwich ELISA microarrays with minimal assay interference. J. Proteome Res. 2008 Jun;7(6):2406-14
Gonzalez RM et al
2008/01/01
Application: ELISA Standard, Sample Type: N/A PubMed
19 Jin F et al. Degradation of BM SDF-1 by MMP-9: the role in G-CSF-induced hematopoietic stem/progenitor cell mobilization. Bone Marrow Transplant. 2008 Nov;42(9):581-8
Jin F et al
2008/01/01
Application: Bioassay, Sample Type: Peptide: SDF-1a PubMed
20 Ito TK et al. Degradation of soluble VEGF receptor-1 by MMP-7 allows VEGF access to endothelial cells. Blood 2009 Mar;113(10):2363-9
Ito TK et al
2009/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
21 Husslein H et al. Expression, regulation and functional characterization of matrix metalloproteinase-3 of human trophoblast. Placenta 2009 Mar;30(3):284-91
Husslein H et al
2009/01/01
Application: Bioassay, Sample Type: Cell Supernate PubMed
22 Tsuchiya S et al. Astacin proteases cleave dentin sialophosphoprotein (Dspp) to generate dentin phosphoprotein (Dpp). J. Bone Miner. Res. 2011 Jan;26(1):220-8
Tsuchiya S et al
2011/01/01
Application: Bioassay PubMed
23 Devel L et al. Simple pseudo-dipeptides with a P2" glutamate: a novel inhibitor family of matrix metalloproteases and other metzincins. J. Biol. Chem. 2012 Aug;287(32):26647-56
Devel L et al
2012/01/01
Application: Enzyme Activity, Sample Type: Mca-PLGL-Dpa-AR-NH2 Fluorogenic MMP Substrate PubMed
24 Djokic J et al. Fibulin-3, -4, and -5 are highly susceptible to proteolysis, interact with cells and heparin, and form multimers. J. Biol. Chem. 2013 Aug;288(31):22821-35
Djokic J et al
2013/01/01
Application: Cleavage, Sample Type: protein PubMed
25 Wang L et al. Astrocytes directly influence tumor cell invasion and metastasis in vivo. PLoS ONE 2013;8(12):e80933
Wang L et al
2013/01/01
Application: Bioassay, Sample Type: cell culture supernate PubMed
26 Thorsen SB et al. Plasma levels of the MMP-9:TIMP-1 complex as prognostic biomarker in breast cancer: a retrospective study. BMC Cancer 2013;13:598
Thorsen SB et al
2013/01/01
Application: Standard, Sample Type: N/A PubMed
27 Zhang Z et al. Proteolytic Cleavage of AMPKα and Intracellular MMP9 Expression Are Both Required for TLR4-Mediated mTORC1 Activation and HIF-1α Expression in Leukocytes. J. Immunol. 2015 Sep;195(5):2452-60
Zhang Z et al
2015/01/01
Application: Bioassay, Sample Type: Cell Lysates PubMed
28 Pei S et al. Plantamajoside, a potential anti-tumor herbal medicine inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of matrix metalloproteinase-9 and -2. BMC Cancer 2015;15:965
Pei S et al
2015/01/01
Application: Bioassay, Sample Type: recombinant protein PubMed
29 Kim BW et al. Pathogenic Upregulation of Glial Lipocalin-2 in the Parkinsonian Dopaminergic System. J. Neurosci. 2016 May;36(20):5608-22
Kim BW et al
2016/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
30 Svalina MN et al. IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma. Sci Rep 2016 Jun;6:27012
Svalina MN et al
2016/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
31 Willumsen N et al. Nidogen-1 Degraded by Cathepsin S can be Quantified in Serum and is Associated with Non-Small Cell Lung Cancer. Neoplasia 2017 Apr;19(4):271-278
Willumsen N et al
2017/01/01
Application: Enzyme Activity, Sample Type: protein PubMed
  • No.: 1
  • 文献情報:
    L辿vesque JP et al. Granulocyte colony-stimulating factor induces the release in the bone marrow of proteases that cleave c-KIT receptor (CD117) from the surface of hematopoietic progenitor cells. Exp. Hematol. 2003 Feb;31(2):109-17
    L辿vesque JP et al
    2003/01/01
  • 備考:
    Species: Human, Application: Enzyme Activity, Sample type: recombinant SCFR
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Breuer E et al. Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids. J. Med. Chem. 2004 May;47(11):2826-32
    Breuer E et al
    2004/01/01
  • 備考:
    Application: Enzyme Activity, Sample type: Fluorogenic Substrate
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Nie J et al. Rapid inactivation of alpha-1-proteinase inhibitor by neutrophil specific leukolysin/membrane-type matrix metalloproteinase 6. Exp. Cell Res. 2004 Jun;296(2):145-50
    Nie J et al
    2004/01/01
  • 備考:
    Application: Enzyme Activity, Sample type: D10 affinity-matured variant of hVbeta2
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Tayebjee MH et al. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Am. J. Hypertens. 2
    Tayebjee MH et al
    2004/01/01
  • 備考:
    Application: ELISA Standard, Sample Type: Plasma (Not Specified)
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Tayebjee MH et al. Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension Relationship to tissue Doppler indices of diastolic relaxation. Am. J. Hypertens. 2004 Sep;17(9):770-4
    Tayebjee MH et al
    2004/01/01
  • 備考:
    Application: ELISA Standard
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Tayebjee MH et al. Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2. Thromb. Res. 2005
    Tayebjee MH et al
    2005/01/01
  • 備考:
    Application: ELISA Standard
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Hashimoto T et al. Suppression of MMP-9 by doxycycline in brain arteriovenous malformations. BMC Neurol 2005 Jan;5(1):1
    Hashimoto T et al
    2005/01/01
  • 備考:
    Application: Zymography Positive Control
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Leufgen H et al. Collagenase expression and activity is modulated by the interaction of collagen types, hypoxia, and nutrition in human lung cells. J. Cell. Physiol. 2005 Jul;204(1):146-54
    Leufgen H et al
    2005/01/01
  • 備考:
    Sample Type: gelatin
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Yan P et al. Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ. J. Biol. Chem. 2006 Aug;281(34):24566-74
    Yan P et al
    2006/01/01
  • 備考:
    Species: Human, Application: Bioassay, Sample type: Amyloid B Fibrils
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Zhou BB et al. Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer. Cancer Cell 2006 Jul;10(1):39-50
    Zhou BB et al
    2006/01/01
  • 備考:
    Application: Enzyme Assay
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Borrelli V et al. Role of platelet-derived growth factor and transforming growth factor beta1 the in the regulation of metalloproteinase expressions. Surgery 2006 Sep;140(3):454-63
    Borrelli V et al
    2006/01/01
  • 備考:
    Species: Human, Application: Western Blot Control, Sample type: Cell Supernates
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Turner NA et al. Selective gene silencing of either MMP-2 or MMP-9 inhibits invasion of human saphenous vein smooth muscle cells. Atherosclerosis 2007 Jul;193(1):36-43
    Turner NA et al
    2007/01/01
  • 備考:
    Species: Human, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Fridman JS et al. Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancer. Clin. Cancer Res. 2007 Mar;13(6):1892-902
    Fridman JS et al
    2007/01/01
  • 備考:
    Application: Bioassay, Sample Type: Peptide Substrate
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Gaggar A et al. Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients. Am. J. Physiol. Lung Cell Mol. Physiol. 2007 Jul;293(1):L96-L104
    Gaggar A et al
    2007/01/01
  • 備考:
    Species: Human, Application: Western Blot Control
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Zhao Z et al. Borrelia burgdorferi-induced monocyte chemoattractant protein-1 production in vivo and in vitro. Biochem. Biophys. Res. Commun. 2007 Jun;358(2):528-33
    Zhao Z et al
    2007/01/01
  • 備考:
    Application: Zymography Positive Control
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Zou Y et al. Targeting matrix metalloproteinases and endothelial cells with a fusion peptide against tumor. Cancer Res. 2007 Aug;67(15):7295-300
    Zou Y et al
    2007/01/01
  • 備考:
    Species: Human, Application: Enzyme Activity
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Mydel P et al. Neutrophil elastase cleaves laminin-332 (laminin-5) generating peptides that are chemotactic for neutrophils. J. Biol. Chem. 2008 Apr;283(15):9513-22
    Mydel P et al
    2008/01/01
  • 備考:
    Species: Human, Application: Enzyme Activity, laminin gamma2 peptide
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Gonzalez RM et al. Development and validation of sandwich ELISA microarrays with minimal assay interference. J. Proteome Res. 2008 Jun;7(6):2406-14
    Gonzalez RM et al
    2008/01/01
  • 備考:
    Application: ELISA Standard, Sample Type: N/A
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Jin F et al. Degradation of BM SDF-1 by MMP-9: the role in G-CSF-induced hematopoietic stem/progenitor cell mobilization. Bone Marrow Transplant. 2008 Nov;42(9):581-8
    Jin F et al
    2008/01/01
  • 備考:
    Application: Bioassay, Sample Type: Peptide: SDF-1a
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Ito TK et al. Degradation of soluble VEGF receptor-1 by MMP-7 allows VEGF access to endothelial cells. Blood 2009 Mar;113(10):2363-9
    Ito TK et al
    2009/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Husslein H et al. Expression, regulation and functional characterization of matrix metalloproteinase-3 of human trophoblast. Placenta 2009 Mar;30(3):284-91
    Husslein H et al
    2009/01/01
  • 備考:
    Application: Bioassay, Sample Type: Cell Supernate
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Tsuchiya S et al. Astacin proteases cleave dentin sialophosphoprotein (Dspp) to generate dentin phosphoprotein (Dpp). J. Bone Miner. Res. 2011 Jan;26(1):220-8
    Tsuchiya S et al
    2011/01/01
  • 備考:
    Application: Bioassay
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Devel L et al. Simple pseudo-dipeptides with a P2" glutamate: a novel inhibitor family of matrix metalloproteases and other metzincins. J. Biol. Chem. 2012 Aug;287(32):26647-56
    Devel L et al
    2012/01/01
  • 備考:
    Application: Enzyme Activity, Sample Type: Mca-PLGL-Dpa-AR-NH2 Fluorogenic MMP Substrate
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Djokic J et al. Fibulin-3, -4, and -5 are highly susceptible to proteolysis, interact with cells and heparin, and form multimers. J. Biol. Chem. 2013 Aug;288(31):22821-35
    Djokic J et al
    2013/01/01
  • 備考:
    Application: Cleavage, Sample Type: protein
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Wang L et al. Astrocytes directly influence tumor cell invasion and metastasis in vivo. PLoS ONE 2013;8(12):e80933
    Wang L et al
    2013/01/01
  • 備考:
    Application: Bioassay, Sample Type: cell culture supernate
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Thorsen SB et al. Plasma levels of the MMP-9:TIMP-1 complex as prognostic biomarker in breast cancer: a retrospective study. BMC Cancer 2013;13:598
    Thorsen SB et al
    2013/01/01
  • 備考:
    Application: Standard, Sample Type: N/A
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Zhang Z et al. Proteolytic Cleavage of AMPKα and Intracellular MMP9 Expression Are Both Required for TLR4-Mediated mTORC1 Activation and HIF-1α Expression in Leukocytes. J. Immunol. 2015 Sep;195(5):2452-60
    Zhang Z et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Pei S et al. Plantamajoside, a potential anti-tumor herbal medicine inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of matrix metalloproteinase-9 and -2. BMC Cancer 2015;15:965
    Pei S et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: recombinant protein
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Kim BW et al. Pathogenic Upregulation of Glial Lipocalin-2 in the Parkinsonian Dopaminergic System. J. Neurosci. 2016 May;36(20):5608-22
    Kim BW et al
    2016/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Svalina MN et al. IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma. Sci Rep 2016 Jun;6:27012
    Svalina MN et al
    2016/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Willumsen N et al. Nidogen-1 Degraded by Cathepsin S can be Quantified in Serum and is Associated with Non-Small Cell Lung Cancer. Neoplasia 2017 Apr;19(4):271-278
    Willumsen N et al
    2017/01/01
  • 備考:
    Application: Enzyme Activity, Sample Type: protein
  • 参照:
    PubMed